SEC Form 4 · accession 0001209191-15-033547
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel L Kisner
Director
Period of report
Apr 8, 2015
Accepted (ET)
Apr 10, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2015 | P | 4,000 | $5.75 | A | 7,145 | D |
Table II — derivative securities
No Table II lines on this filing.